GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
Patent Applications and Registrations
Patent applications and USPTO patent grants for GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED.The latest application filed is for "pyridyl or pyrimidyl mtor kinase inhibitors".
Company Profile
200.200.200
- GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED - Brentford, Middlesex GB
- GlaxoSmithKline Intellectual Property Development Limited - Brentford GB
- GlaxoSmithKline Intellectual Property Development Limited - Middlesex GB
- GlaxoSmithKline Intellectual Property Development Limited - N/A
- GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED - Brenford, Middlesex GB
- GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED - Brentfold GB
- GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED. - Brentford GB
- GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED - Brenttord GB
Patent Activity
| Patent | Date |
|---|---|
| Pyridyl Or Pyrimidyl Mtor Kinase Inhibitors App 20220306623 - BERTRAND; Sophie Marie ; et al. | 2022-09-29 |
| Compounds for the treatment of parasitic infections Grant 11,453,657 - Castellote Alvaro , et al. September 27, 2 | 2022-09-27 |
| Novel Compounds App 20220298197 - BISHOP; Michael Joseph ; et al. | 2022-09-22 |
| Biopharmacuetical Compositions and Related Methods App 20220289859 - Kranz; James K. ; et al. | 2022-09-15 |
| Modular aseptic production system Grant 11,434,032 - Sanmartin September 6, 2 | 2022-09-06 |
| Targeted protein degradation Grant 11,427,643 - Brayshaw , et al. August 30, 2 | 2022-08-30 |
| Substituted Biphenyl Or Phenylheteroaryl-mannosides As Antagonists Of Fimh App 20220242900 - BISHOP; Michael Joseph ; et al. | 2022-08-04 |
| Combination treatment for cancer with anti-BCMA binding protein and proteosome inhibitor Grant 11,401,334 - Khandekar , et al. August 2, 2 | 2022-08-02 |
| Mannose-derived Antagonists Of Fimh Useful For Treating Disease App 20220235087 - JANETKA; James W. ; et al. | 2022-07-28 |
| Matrix Composition Comprising (s)-5-benzyl-n-(5-methyl-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-3-- Yl)-4h-1,2,4-triazole-3-carboxamide App 20220218719 - APFELBAUM; Rachel ; et al. | 2022-07-14 |
| Ghrelin O-acyltransferase Inhibitors App 20220213076 - Bandyopadhyay; Anish ; et al. | 2022-07-07 |
| Modulators of stimulator of interferon genes (STING) Grant 11,377,440 - Fosbenner , et al. July 5, 2 | 2022-07-05 |
| Hydroxypyridoxazepines As Nrf2 Activators App 20220204526 - ELBAN; Mark ; et al. | 2022-06-30 |
| Heterocyclic amides useful as protein modulators Grant 11,365,190 - Charnley , et al. June 21, 2 | 2022-06-21 |
| Gepotidacin For Use In The Treatment Of Bacterial Urinary Tract Infections App 20220184071 - PAYNE; David John ; et al. | 2022-06-16 |
| Process For The Purification Of Recombinant Polypeptides App 20220177517 - GIBSON; Daniel ; et al. | 2022-06-09 |
| Adeno-associated Viral Vector Producer Cell Lines App 20220177854 - CHANAS; Simon Alexander ; et al. | 2022-06-09 |
| Prognostic method Grant 11,353,458 - Bounds , et al. June 7, 2 | 2022-06-07 |
| Combination Therapy With An Anti Bcma Antibody And A Gamma Secretase Inhibitor App 20220168417 - BISWAS; Swethajit ; et al. | 2022-06-02 |
| IL-7 Binding Proteins and Their use in Medical Therapy App 20220169717 - BOUMA; Gerben ; et al. | 2022-06-02 |
| Chemical Compounds App 20220144834 - CATALANO; John G. ; et al. | 2022-05-12 |
| Ghrelin O-acyltransferase inhibitors Grant 11,312,709 - Bandyopadhyay , et al. April 26, 2 | 2022-04-26 |
| Compounds Useful in HIV Therapy App 20220119417 - DE LA ROSA; Martha ; et al. | 2022-04-21 |
| Mrgx2 Antagonists App 20220112174 - BRNARDIC; Edward ; et al. | 2022-04-14 |
| Belantamab Mafodotin In Combination With Pembrolizumab For Treating Cancer App 20220096650 - OPALINSKA; Joanna | 2022-03-31 |
| Combination Treatments For Cancer Comprising Belantamab Mafodotin And An Anti Ox40 Antibody And Uses And Methods Thereof App 20220098303 - Biswas; Swethajit ; et al. | 2022-03-31 |
| Ether Linked Triazoles As Nrf2 Activators App 20220089590 - Cooper; Anthony William James ; et al. | 2022-03-24 |
| Antigen Binding Proteins App 20220089728 - DEGENHARDT; Yan Y. ; et al. | 2022-03-24 |
| Compounds useful in HIV therapy Grant 11,274,102 - Favre , et al. March 15, 2 | 2022-03-15 |
| Icos Binding Proteins App 20220064299 - LIU; Yao-Bin ; et al. | 2022-03-03 |
| Compounds Grant 11,254,689 - Porras De Francisco , et al. February 22, 2 | 2022-02-22 |
| Compounds Grant 11,253,499 - Porras De Francisco , et al. February 22, 2 | 2022-02-22 |
| Chemical compounds Grant 11,254,671 - Bravi , et al. February 22, 2 | 2022-02-22 |
| Antibodies with reduced binding to process impurities Grant 11,254,753 - Bosteels , et al. February 22, 2 | 2022-02-22 |
| Sanfetrinem or a salt or ester thereof for use in treating mycobacterial infection Grant 11,253,500 - Barros Aguirre , et al. February 22, 2 | 2022-02-22 |
| Immunogenic Composition, Use And Method Of Treatment App 20220023409 - COHET; Catherine ; et al. | 2022-01-27 |
| Method for treating gonorrhea with (2R)-2-({4-[(3,4-dihydro-2H-pyrano[2,3-C]pyridin-6-ylmethyl)amino]-1-pipe- ridinyl}methyl)-1,2-dihydro-3H,8H-2A,5,8A-triazaacenaphthylene-3,8-dione Grant 11,229,646 - Widdowson January 25, 2 | 2022-01-25 |
| Chemical Compounds App 20220009918 - Cadilla; Rodolfo ; et al. | 2022-01-13 |
| Bisaryl Lactams As Nrf2 Activators App 20220002272 - BOEHM; Jeffrey Charles ; et al. | 2022-01-06 |
| Methods Of Treating Cancer App 20220003772 - DETTMAN; Elisha J. ; et al. | 2022-01-06 |
| C-mannoside Compounds Useful For The Treatment Of Urinary Tract Infections App 20210395287 - BISHOP; Michael Joseph ; et al. | 2021-12-23 |
| Dosing App 20210395367 - PAUL; Elaine Marie ; et al. | 2021-12-23 |
| Antibody variants Grant 11,203,632 - Damian , et al. December 21, 2 | 2021-12-21 |
| Combination Of Prmt5 Inhibitors And Bcl-2 Inhibitors App 20210386738 - BARBASH; Olena | 2021-12-16 |
| PI4KIIIbeta Inhibitors App 20210387988 - BARTON; Nicholas Paul ; et al. | 2021-12-16 |
| Combination therapy Grant 11,197,857 - Barbash , et al. December 14, 2 | 2021-12-14 |
| Non Peptidic Heterobivalent Molecules For Treating Inflammatory Diseases App 20210379044 - BAILEY; James ; et al. | 2021-12-09 |
| Enzyme And Receptor Modulation App 20210361772 - DAVIDSON; Alan Hornsby ; et al. | 2021-11-25 |
| Modular Aseptic Production System App 20210362898 - SANMARTIN; Francesco | 2021-11-25 |
| Binding Agonist For Treatment Of Neurological And Other Disorders App 20210347902 - BHINDER; Tejinder Kaur ; et al. | 2021-11-11 |
| Immunogenic composition, use and method of treatment Grant 11,167,022 - Cohet , et al. November 9, 2 | 2021-11-09 |
| Dosing App 20210324081 - PAUL; Elaine Marie ; et al. | 2021-10-21 |
| Chemical compounds as H--PGDS inhibitors Grant 11,149,035 - Deaton , et al. October 19, 2 | 2021-10-19 |
| Treatment Regimen App 20210308131 - SCANGARELLA-OMAN; Nicole ; et al. | 2021-10-07 |
| ICOS binding proteins Grant 11,130,811 - Liu , et al. September 28, 2 | 2021-09-28 |
| Methods For Purifying Antibodies App 20210284686 - DUMETZ; Andre C. ; et al. | 2021-09-16 |
| Wireless mechanism for detecting an open or closed container, and methods of making and using the same Grant 11,119,158 - Mukherjee , et al. September 14, 2 | 2021-09-14 |
| Bisaryl heterocycles as NRF2 activators Grant 11,117,905 - Callahan , et al. September 14, 2 | 2021-09-14 |
| C-mannoside compounds useful for the treatment of urinary tract infections Grant 11,111,262 - Bishop , et al. September 7, 2 | 2021-09-07 |
| Combined Therapy With Icos Binding Proteins And Argininemethyltransferase Inhibitors App 20210260033 - FEDORIW; Andrew Mark ; et al. | 2021-08-26 |
| Method of producing a recombinant protein Grant 11,098,312 - Emmins , et al. August 24, 2 | 2021-08-24 |
| Chemical Compounds App 20210253528 - DEMARTINO; Michael P. ; et al. | 2021-08-19 |
| Heterocyclic Amides as Kinase Inhibitors App 20210253532 - Anderson; Niall Andrew ; et al. | 2021-08-19 |
| Chemical Compounds App 20210238162 - CADILLA; Rodolfo ; et al. | 2021-08-05 |
| Heterocyclic Amides Useful As Protein Modulators And Methods Of Using The Same App 20210238172 - CHARNLEY; Adam Kenneth ; et al. | 2021-08-05 |
| Bisaryl amides as NRF2 activators Grant 11,078,216 - Callahan , et al. August 3, 2 | 2021-08-03 |
| Binding agonist for treatment of neurological and other disorders Grant 11,078,287 - Bhinder , et al. August 3, 2 | 2021-08-03 |
| Tetrazole compounds and their use in the treatment of tuberculosis Grant 11,072,591 - Alemparte-Gallardo , et al. July 27, 2 | 2021-07-27 |
| Ether linked triazoles as NRF2 activators Grant 11,059,816 - Cooper , et al. July 13, 2 | 2021-07-13 |
| Naphthyridines As Integrin Antagonists App 20210206758 - ANDERSON; Niall Andrew ; et al. | 2021-07-08 |
| Benzimidazole derivatives as bromodomain inhibitors Grant 11,053,212 - Bit , et al. July 6, 2 | 2021-07-06 |
| 1,3 di-substituted cyclobutane or azetidine derivatives as hematopoietic prostaglandin D synthase inhibitors Grant 11,053,234 - Deaton , et al. July 6, 2 | 2021-07-06 |
| Modulators Of Indoleamine 2,3-dioxygenase App 20210186960 - KAZMIERSKI; Wieslaw Mieczyslaw | 2021-06-24 |
| Methods Of Preparing Stable Liquid Therapeutic Protein Compositions App 20210187107 - ALAZZAM; Wasfi Abdel Karim ; et al. | 2021-06-24 |
| Nrf2 Activator For The Treatment Of Acute Lung Injury, Acute Respiratory Distress Syndrome And Multiple Organ Dysfunction Syndrome App 20210177861 - RUMSEY; William | 2021-06-17 |
| Compounds for inhibiting LRRK2 kinase activity Grant 11,034,696 - Ren , et al. June 15, 2 | 2021-06-15 |
| NRF2 activators Grant 11,028,099 - Brooks , et al. June 8, 2 | 2021-06-08 |
| Chemical Compounds App 20210163472 - BRAVI; Gianpaolo ; et al. | 2021-06-03 |
| Dosage Regimen App 20210155687 - REID; Juliet ; et al. | 2021-05-27 |
| Combination Therapy App 20210155903 - BI; Meixia ; et al. | 2021-05-27 |
| N-(3-(2-(4-chlorophenoxy)acetamido)bicyclo[1.1.1] Pentan-1-yl)-2-cyclobutane-1- Carboxamide Derivatives And Related Compounds As Atf4 Inhibitors For Treating Cancer And Other Diseases App 20210145771 - CHEUNG; Mui ; et al. | 2021-05-20 |
| Heterocyclic Amides Useful As Protein Modulators App 20210139473 - CHARNLEY; Adam Kenneth ; et al. | 2021-05-13 |
| Fused Pyridines Which Act As Inhibitors Of H Pgds App 20210139507 - DEATON; David Norman ; et al. | 2021-05-13 |
| Modulators Of Indoleamine 2,3-dioxygenase App 20210139467 - DE LA ROSA; Martha Alicia ; et al. | 2021-05-13 |
| Compounds App 20210130339 - REN; Feng ; et al. | 2021-05-06 |
| Fluticasone furoate in the treatment of COPD Grant 10,987,363 - Barnes , et al. April 27, 2 | 2021-04-27 |
| Biopharmaceutical Compositions Comprising Antibody Variants App 20210115128 - AKINSEYE; Chika ; et al. | 2021-04-22 |
| Carboxyesterase Biocatalysts App 20210115417 - BROWN; Kristin K. ; et al. | 2021-04-22 |
| Heterocyclic amides useful as protein modulators Grant 10,981,901 - Romano , et al. April 20, 2 | 2021-04-20 |
| Combination Therapy App 20210106580 - BARBASH; Olena I. ; et al. | 2021-04-15 |
| Parvovirus Vector Production App 20210108227 - HERRING; Christopher | 2021-04-15 |
| Substituted pyridines as inhibitors of DNMT1 Grant 10,975,056 - Adams , et al. April 13, 2 | 2021-04-13 |
| Heterocyclic amides useful as protein modulators Grant 10,975,287 - Charnley , et al. April 13, 2 | 2021-04-13 |
| Substituted fused pyrazole compounds and their use as LRRK2 inhibitors Grant 10,975,081 - Ding , et al. April 13, 2 | 2021-04-13 |
| Chemical Compounds as ATF-4 Pathway Inhibitors App 20210093619 - AXTEN; Jeffrey Michael ; et al. | 2021-04-01 |
| Heterocyclic amides as kinase inhibitors Grant 10,961,258 - Jeong March 30, 2 | 2021-03-30 |
| Modulators Of Indoleamine 2,3-dioxygenase App 20210078988 - EVINDAR; Ghotas ; et al. | 2021-03-18 |
| Heterocyclic amides as kinase inhibitors Grant 10,940,154 - Jeong , et al. March 9, 2 | 2021-03-09 |
| Methods for Adeno-Associated Viral Vector Production App 20210062161 - VINK; Conrad | 2021-03-04 |
| Heterocyclic amides as kinase inhibitors Grant 10,933,070 - Jeong , et al. March 2, 2 | 2021-03-02 |
| Methods For Purifying Recombinant Polypeptides App 20210054051 - DUMETZ; Andre ; et al. | 2021-02-25 |
| Substituted Benzazinones As Antibacterial Compounds App 20210053926 - JIN; Qi ; et al. | 2021-02-25 |
| Ghrelin O-acyltransferase Inhibitors App 20210053955 - Bandyopadhyay; Anish ; et al. | 2021-02-25 |
| Modulators of indoleamine 2,3-dioxygenase Grant 10,927,078 - De La Rosa , et al. February 23, 2 | 2021-02-23 |
| Novel Compounds For The Treatment Of Parasitic Infections App 20210047299 - CASTELLOTE ALVARO; Maria Isabel ; et al. | 2021-02-18 |
| Novel Compounds App 20210032268 - PORRAS DE FRANCISCO; Esther ; et al. | 2021-02-04 |
| Modulators of indoleamine 2,3-dioxygenase Grant 10,906,924 - De La Rosa , et al. February 2, 2 | 2021-02-02 |
| Modulators of indoleamine 2,3-dioxygenase Grant 10,899,754 - De La Rosa , et al. January 26, 2 | 2021-01-26 |
| Heterocyclic amides as kinase inhibitors Grant 10,899,716 - Anderson , et al. January 26, 2 | 2021-01-26 |
| Biopharmaceutical Compositions And Related Methods App 20210017269 - GRANT; Steven ; et al. | 2021-01-21 |
| C-mannoside Compounds Useful For The Treatment Of Urinary Tract Infections App 20210017212 - BISHOP; Michael Joseph ; et al. | 2021-01-21 |
| Compounds Useful in HIV Therapy App 20210009609 - DE LA ROSA; Martha ; et al. | 2021-01-14 |
| Compounds useful in HIV therapy Grant 10,870,663 - Dunham , et al. December 22, 2 | 2020-12-22 |
| Inhibitors Of Leucine Rich Repeat Kinase 2 App 20200392158 - DING; Xiao ; et al. | 2020-12-17 |
| Methods for adeno-associated viral vector production Grant 10,858,631 - Vink December 8, 2 | 2020-12-08 |
| Compounds Grant 10,858,367 - Ding , et al. December 8, 2 | 2020-12-08 |
| Chemical compounds Grant 10,851,053 - Axten , et al. December 1, 2 | 2020-12-01 |
| Antibody Variants App 20200339663 - DAMIAN; Valeriu ; et al. | 2020-10-29 |
| Benzoimidazole derivatives as PAD4 inhibitors Grant 10,815,218 - Amans , et al. October 27, 2 | 2020-10-27 |
| Tricyclic Nitrogen Containing Compounds For Treating Neisseria Gonorrhoea Infection App 20200330462 - WIDDOWSON; Katherine Louisa | 2020-10-22 |
| Methods for Administering STING Agonists App 20200330556 - PESIRIDIS; George Scott ; et al. | 2020-10-22 |
| Powder formulation Grant 10,806,770 - Mitchell October 20, 2 | 2020-10-20 |
| Compounds Useful in HIV Therapy App 20200325147 - FAVRE; David ; et al. | 2020-10-15 |
| Heterocyclic Amides Useful As Protein Modulators App 20200325126 - CHARNLEY; Adam Kenneth ; et al. | 2020-10-15 |
| NOPE for treatment of pathological muscle loss and weakness Grant 10,799,559 - Hinken , et al. October 13, 2 | 2020-10-13 |
| Chemical compounds Grant 10,793,559 - Anderson , et al. October 6, 2 | 2020-10-06 |
| Modulators of indoleamine 2,3-dioxygenase Grant 10,787,442 - Catalano , et al. September 29, 2 | 2020-09-29 |
| Biopharmaceutical compositions and related methods Grant 10,787,509 - Grant , et al. September 29, 2 | 2020-09-29 |
| Compounds Useful in HIV Therapy App 20200299309 - DUNHAM; Richard M ; et al. | 2020-09-24 |
| Chemical Compounds App 20200297710 - AXTEN; Jeffrey Michael ; et al. | 2020-09-24 |
| Conjugates comprising RIPK2 inhibitors Grant 10,781,205 - Casillas , et al. Sept | 2020-09-22 |
| Substituted benzazinones as antibacterial compounds Grant 10,781,184 - Jin , et al. Sept | 2020-09-22 |
| Modulators Of Indoleamine 2,3-dioxygenase App 20200291008 - KAZMIERSKI; Wieslaw M. ; et al. | 2020-09-17 |
| Citrate Salt Of The Compound (s)-4-((s)-3-fluoro-3-(2-(5,6,7,8-tetrahydro-1,8-naphthydrin-2-yl)ethyl)p- Yrrolidin-1-yl)-3-(3-(2-methoxyethoxy)phenyl) Butanoic Acid App 20200291017 - BARRETT; Tim ; et al. | 2020-09-17 |
| Sanfetrinem Or A Salt Or Ester Thereof For Use In Treating Mycobacterial Infection App 20200289462 - BARROS AGUIRRE; David ; et al. | 2020-09-17 |
| Targeted Protein Degradation App 20200283538 - Brayshaw; Lewis Lee ; et al. | 2020-09-10 |
| TLR4 agonists and compositions thereof and their use in the treatment of cancer Grant 10,765,690 - Cluff , et al. Sep | 2020-09-08 |
| Novel Processes For The Production Of Oligonucleotides App 20200277659 - CRAMERI; Andreas ; et al. | 2020-09-03 |
| Heterocyclic Amides As Kinase Inhibitors App 20200270273 - JEONG; Jae U. | 2020-08-27 |
| Combination Treatment For Cancer App 20200270354 - KHANDEKAR; Sanjay ; et al. | 2020-08-27 |
| Chemical Compounds App 20200255428 - Kind Code | 2020-08-13 |
| Combination Treatment For Cancer App 20200254093 - Kind Code | 2020-08-13 |
| Novel Compounds App 20200253967A1 - | 2020-08-13 |
| Combination Treatment For Cancer App 20200255526 - Kind Code | 2020-08-13 |
| Compounds and methods for the enhanced degradation of targeted proteins and other polypeptides by an E3 ubiquitin ligase Grant 10,730,862 - Crews , et al. | 2020-08-04 |
| Compounds Grant 10,730,907 - Adams , et al. | 2020-08-04 |
| Modulators Of Indoleamine 2,3-dioxygenase App 20200239420 - KAZMIERSKI; Wieslaw Mieczyslaw | 2020-07-30 |
| Treatment Paradigm App 20200231666 - TAK; Paul-Peter | 2020-07-23 |
| Novel Tetrazole Compounds And Their Use In The Treatment Of Tuberculosis App 20200231555 - ALEMPARTE-GALLARDO; Carlos ; et al. | 2020-07-23 |
| Amino quinazolines as kinase inhibitors Grant 10,717,711 - Charnley , et al. | 2020-07-21 |
| Compounds as rearranged during transfection (RET) inhibitors Grant 10,709,695 - Demartino , et al. | 2020-07-14 |
| Methods for treating neisseria gonorrhoeae infection with substituted 1,2-dihydro-2A,5,8A-triazaacenaphthylene-3,8-diones Grant 10,702,521 - Widdowson | 2020-07-07 |
| Combination Therapy With Icos Agonist And Ox40 Agonist To Treat Cancer App 20200190195 - HOPSON; Christopher B. ; et al. | 2020-06-18 |
| Combination Therapy App 20200190194 - BI; Meixia ; et al. | 2020-06-18 |
| Targeted protein degradation Grant 10,683,360 - Brayshaw , et al. | 2020-06-16 |
| Compounds for use in antibacterial applications Grant 10,683,307 - Cui , et al. | 2020-06-16 |
| Combination Therapy With Icos Agonist And Ox40 Agonist To Treat Cancer App 20200181275 - HOPSON; Christopher B. ; et al. | 2020-06-11 |
| Crystalline hydrate of the compound (2S,3R)-isopropyl 2-(((2-(1,5-dimethyl-6-oxo-1,6-dihydropyridin-3-yl)-1-((tetrahydro-2H-pyr- an-4-yl)methyl)-1H-benzo[D]imidazol-5- yl)methyl)amino)-3-hydroxybutanoate edisylate Grant 10,676,466 - Henley | 2020-06-09 |
| Binding Agonist For Treatment Of Neurological And Other Disorders App 20200165345 - BHINDER; Tejinder Kaur ; et al. | 2020-05-28 |
| Modulators Of Indoleamine 2,3-dioxygenase App 20200165201 - DE LA ROSA; Martha Alicia ; et al. | 2020-05-28 |
| Heterocyclic Amides As Kinase Inhibitors App 20200165205 - ANDERSON; Niall Andrew ; et al. | 2020-05-28 |
| Modulators Of Indoleamine 2,3-dioxygenase App 20200165280 - DE LA ROSA; Martha Alicia ; et al. | 2020-05-28 |
| PRMT5 inhibitors and uses thereof Grant 10,653,693 - Duncan , et al. | 2020-05-19 |
| Icos Binding Proteins App 20200140551 - LIU; Yao-Bin ; et al. | 2020-05-07 |
| 2-(4-chlorophenoxy)-n-((1 -(2-(4-chlorophenoxy)ethynazetidin-3-yl)methyl)acetamide Derivatives And Related Compounds As Atf4 Inh App 20200140383 - CHEUNG; Mui ; et al. | 2020-05-07 |
| Processes for the production of oligonucleotides Grant 10,640,812 - Crameri , et al. | 2020-05-05 |
| Chemical Compounds as H-PGDS Inhibitors App 20200123152 - DEATON; David Norman ; et al. | 2020-04-23 |
| Icos Binding Proteins App 20200123257 - LIU; Yao-Bin ; et al. | 2020-04-23 |
| Stable Cell Lines For Retroviral Production App 20200123505 - JOHNSON; Sabine ; et al. | 2020-04-23 |
| Antituberculosis agent Grant 10,624,893 - Ballell Pages , et al. | 2020-04-21 |
| Modulators Of Indoleamine 2,3-dioxygenase App 20200115374 - DE LA ROSA; Martha Alicia ; et al. | 2020-04-16 |
| LRRK2 inhibitors for the treatment of Parkinson's disease Grant 10,618,901 - Ding , et al. | 2020-04-14 |
| Method of treating pancreatitis using 1,4-benzoxazine derivatives Grant 10,611,756 - Bouillot , et al. | 2020-04-07 |
| Nrf2 regulators Grant 10,604,509 - Kerns , et al. | 2020-03-31 |
| Benzoimidazole Derivatives As Pad4 Inhibitors App 20200095227 - AMANS; Dominique ; et al. | 2020-03-26 |
| Prodrug of 1,1'-(1,6-dioxo-1,6-hexanediyl)bis-D-proline Grant 10,597,385 - Denis , et al. | 2020-03-24 |
| TRPV4 antagonists Grant 10,590,077 - Brnardic , et al. | 2020-03-17 |
| TRPV4 antagonists Grant 10,588,891 - Brnardic , et al. | 2020-03-17 |
| Heterocyclic amides as kinase inhibitors Grant 10,590,085 - Anderson , et al. | 2020-03-17 |
| Nrf2 REGULATORS App 20200079759 - KERNS; Jeffrey K. ; et al. | 2020-03-12 |
| Compounds App 20200079777 - DING; Xiao ; et al. | 2020-03-12 |
| Ingenol analogs, pharmaceutical compositions and methods of use thereof Grant 10,583,140 - Tai , et al. | 2020-03-10 |
| Ether Linked Triazoles As Nrf2 Activators App 20200071317A1 - | 2020-03-05 |
| Chemical Compounds App 20200071311 - ANDERSON; Niall Andrew ; et al. | 2020-03-05 |
| N-aryl Pyrazoles As Nrf2 Regulators App 20200071310 - BUDZIK; Brian W. ; et al. | 2020-03-05 |
| Heterocyclic Amides As Kinase Inhibitors App 20200062735 - ANBARI; Jill Marinis ; et al. | 2020-02-27 |
| Bisaryl Heterocycles As Nrf2 Activators App 20200062781 - CALLAHAN; James Francis ; et al. | 2020-02-27 |
| Transient Transfection Method For Retroviral Production App 20200063144 - JOHNSON; Sabine ; et al. | 2020-02-27 |
| Compounds App 20200055863 - WAN; Zehong ; et al. | 2020-02-20 |
| Immunogenic Composition, Use And Method Of Treatment App 20200046823 - COHET; Catherine ; et al. | 2020-02-13 |
| Benzimidazole Derivatives As Bromodomain Inhibitors App 20200039953 - BIT; Rino Antonio ; et al. | 2020-02-06 |
| Nrf2 Activators App 20200031846 - BROOKS; Carl A. ; et al. | 2020-01-30 |
| Modulators of indoleamine 2,3-dioxygenase Grant 10,538,495 - Johns , et al. Ja | 2020-01-21 |
| Compounds App 20200002323 - CUI; Haifeng ; et al. | 2020-01-02 |
| Novel Compounds App 20200002370 - ADAMS; Jerry ; et al. | 2020-01-02 |
| Compounds App 20190389850 - REN; Feng ; et al. | 2019-12-26 |
| Naphthyridine derivatives as alpha V beta 6 integrin antagonists for the treatment of E.G. fibrotic diseases Grant 10,513,517 - Anderson , et al. Dec | 2019-12-24 |
| Antigen Binding Proteins App 20190382482 - HAMBLIN; Paul Andrew ; et al. | 2019-12-19 |
| Novel Compounds App 20190382381 - CASILLAS; Linda N. ; et al. | 2019-12-19 |
| Combination Treatment For Cancer App 20190375847 - CORTEZ; Maria Angelica ; et al. | 2019-12-12 |
| Methods Of Treating Cancer App 20190365710 - FEDORIW; Andy ; et al. | 2019-12-05 |
| Compounds For Inhibiting Lrrk2 Kinase Activity App 20190359618 - REN; Feng ; et al. | 2019-11-28 |
| Compounds App 20190359623 - DING; Xiao ; et al. | 2019-11-28 |
| Naphthyridines as integrin antagonists Grant 10,487,080 - Anderson , et al. Nov | 2019-11-26 |
| Nrf2 regulators Grant 10,485,806 - Kerns , et al. Nov | 2019-11-26 |
| Combination Therapy App 20190350931 - BARBASH; Olena I. ; et al. | 2019-11-21 |
| Compounds Grant 10,479,792 - Brand , et al. Nov | 2019-11-19 |
| 3-(5-chloro-2-oxobenzo[d]oxazol-3(2h)-yl) Propanoic Acid Derivatives As Kmo Inhibitors App 20190345117 - BOUILLOT; Anne Marie Jeanne ; et al. | 2019-11-14 |
| Combination Therapy App 20190343803 - BARBASH; Olena I. ; et al. | 2019-11-14 |
| Heterocyclic Amides As Kinase Inhibitors App 20190345138 - DAUGAN; Alain Claude-Marie ; et al. | 2019-11-14 |
| Modulators of indoleamine 2,3-dioxygenase Grant 10,472,336 - Chong , et al. Nov | 2019-11-12 |
| Soluble guanylate cyclase activators and their use Grant 10,472,350 - Dodic , et al. Nov | 2019-11-12 |
| Non Peptide Heterobivalent Molecules For Treating Inflammatory Diseases App 20190336489 - BAILEY; James ; et al. | 2019-11-07 |
| Methods Of Treatment App 20190338042 - FRANCIS; Christopher John ; et al. | 2019-11-07 |
| Bisaryl Amides As Nrf2 Activators App 20190330238 - CALLAHAN; James Francis ; et al. | 2019-10-31 |
| Antibody-drug Conjugates And Therapeutic Methods Using The Same App 20190328900 - JEFFREY; Jerry ; et al. | 2019-10-31 |
| Chemical compounds Grant 10,457,674 - Anderson , et al. Oc | 2019-10-29 |
| Treatment Paradigm App 20190322734 - TAK; Paul-Peter | 2019-10-24 |
| Transient transfection method for retroviral production Grant 10,450,574 - Johnson , et al. Oc | 2019-10-22 |
| Cyclic di-nucleotides as modulators of STING Grant 10,450,341 - Biggadike , et al. Oc | 2019-10-22 |
| Naphthyridine derivatives useful as alpha-V-beta-6 integrin antagonists Grant 10,450,312 - Anderson , et al. Oc | 2019-10-22 |
| Benzimidazole derivatives as bromodomain inhibitors Grant 10,442,786 - Bit , et al. Oc | 2019-10-15 |
| Compounds Grant 10,435,391 - Casillas , et al. O | 2019-10-08 |
| Chemical Compounds App 20190298705 - AXTEN; Jeffrey Michael ; et al. | 2019-10-03 |
| Compounds Grant 10,428,078 - Wan , et al. October 1, 2 | 2019-10-01 |
| Antigen Binding Proteins App 20190276535 - HAMBLIN; Paul Andrew ; et al. | 2019-09-12 |
| NOVEL COMPOUNDS avB6 INTEGRIN ANTAGONISTS. App 20190275016 - ANDERSON; Niall Andrew ; et al. | 2019-09-12 |
| Benzoimidazole derivatives as PAD4 inhibitors Grant 10,407,407 - Amans , et al. Sept | 2019-09-10 |
| Compounds For Use In Antibacterial Applications App 20190270755 - CUI; Haifeng ; et al. | 2019-09-05 |
| Novel Compounds App 20190263798 - HARLING; John David ; et al. | 2019-08-29 |
| Heterocyclic Amides As Kinase Inhibitors App 20190262356 - JEONG; Jae U. ; et al. | 2019-08-29 |
| Anti-icos And Anti-pd-1 Antibody Combination Therapy App 20190256599 - BHATTACHARYA; Sabyasachi ; et al. | 2019-08-22 |
| Combination Treatments And Uses And Methods Thereof App 20190256608 - MAYES; Patrick A. ; et al. | 2019-08-22 |
| Novel Compounds As Rearranged During Transfection (ret) Inhibitors App 20190247382 - Demartino; Michael P. ; et al. | 2019-08-15 |
| 1,3 Di-substituted Cyclobutane Or Azetidine Derivatives As Hematopoietic Prostaglandin D Synthase Inhibitors App 20190241554 - DEATON; David Norman ; et al. | 2019-08-08 |
| Isoquinoline Derivatives As Perk Inhibitors App 20190241573 - AXTEN; Jeffrey Michael ; et al. | 2019-08-08 |
| Enzyme And Receptor Modulation App 20190231887 - DAVIDSON; Alan Hornsby ; et al. | 2019-08-01 |
| Biaryl pyrazoles as NRF2 regulators Grant 10,364,256 - Callahan , et al. | 2019-07-30 |
| Compounds Grant 10,364,266 - Adams , et al. | 2019-07-30 |
| Compounds for use in antibacterial applications Grant 10,364,254 - Cui , et al. | 2019-07-30 |
| Nrf2 REGULATORS App 20190224212 - Kerns; Jeffrey K. ; et al. | 2019-07-25 |
| Antibodies With Reduced Binding To Process Impurities App 20190225708 - BOSTEELS; Hella ; et al. | 2019-07-25 |
| Modulators of indoleamine 2,3-dioxygenase Grant 10,358,427 - Chong , et al. July 23, 2 | 2019-07-23 |
| Arylcyclohexyl pyrazoles as NRF2 regulators Grant 10,351,530 - Callahan , et al. July 16, 2 | 2019-07-16 |
| ICOS binding proteins Grant 10,351,627 - Liu , et al. July 16, 2 | 2019-07-16 |
| Novel Compounds App 20190210996 - HARLING; John David ; et al. | 2019-07-11 |
| Antigen binding proteins Grant 10,344,088 - Hamblin , et al. July 9, 2 | 2019-07-09 |
| Compounds .alpha..sub.v.beta..sub.6 integrin antagonists Grant 10,342,783 - Anderson , et al. July 9, 2 | 2019-07-09 |
| Heterocyclic Amides As Kinase Inhibitors App 20190201413 - JEONG; Jae U. ; et al. | 2019-07-04 |
| 1AP E3 ligase directed proteolysis targeting chimeric molecules Grant 10,336,744 - Harling , et al. | 2019-07-02 |
| 1-(cyclopent-2-en-1-yl)-3-(2-hydroxy-3-(arylsulfonyl)phenyl)urea derivatives as CXCR2 inhibitors Grant 10,336,719 - Chen , et al. | 2019-07-02 |
| Substituted Pyridines As Inhibitors Of Dnmt1 App 20190194166 - ADAMS; Nicholas David ; et al. | 2019-06-27 |
| D-proline derivatives as SAP depleting agent Grant 10,328,052 - Denis , et al. | 2019-06-25 |
| Crystalline Hydrate Of The Compound (2s,3r)-isopropyl 2-(((2-(1,5-dimethyl-6-oxo-1,6-dihydropyridin-3-yl)-1-((tetrahydro-2h-pyr- App 20190177307 - HENLEY; Nicholas Paul | 2019-06-13 |
| Method of Producing a Recombinant Protein App 20190177734 - EMMINS; Robyn Alexandra ; et al. | 2019-06-13 |
| Methods App 20190169178 - BOUILLOT; Anne Marie Jeanne ; et al. | 2019-06-06 |
| Chemical Compounds App 20190161480 - CAMPOS; Sebastien Andre ; et al. | 2019-05-30 |
| Novel Compounds App 20190152946 - HARLING; John David ; et al. | 2019-05-23 |
| Heterocyclic amides as kinase inhibitors Grant 10,292,987 - Jeong , et al. | 2019-05-21 |
| Compounds as rearranged during transfection (RET) inhibitors Grant 10,294,236 - Cheung , et al. | 2019-05-21 |
| Compounds as rearranged during transfection (RET) inhibitors Grant 10,292,975 - Demartino , et al. | 2019-05-21 |
| Covalent Conjugates App 20190142949 - BROWN; John Alexander ; et al. | 2019-05-16 |
| Chemical Compounds App 20190144384 - AXTEN; Jeffrey Michael ; et al. | 2019-05-16 |
| Treating Respiratory Diseases By Targeting Interleukin 4 Induced 1 (il4i1) App 20190135911 - SULLIVAN; Kathleen M. ; et al. | 2019-05-09 |
| Nope For Treatment Of Pathological Muscle Loss And Weakness App 20190125833 - Hinken; Aaron Curtis ; et al. | 2019-05-02 |
| Powder Formulation App 20190125824 - MITCHELL; James John | 2019-05-02 |
| Inhibition Of Tgfbeta In Immunotherapy App 20190119387 - BRETT; Sara Jane | 2019-04-25 |
| Modulators Of Indoleamine 2,3-dioxygenase App 20190119223 - JOHNS; Brian Alvin ; et al. | 2019-04-25 |
| Conjugates Comprising Ripk2 Inhibitors App 20190119271 - CASILLAS; Linda N. ; et al. | 2019-04-25 |
| Naphthyridines As Integrin Antagonists App 20190112306 - ANDERSON; Niall Andrew ; et al. | 2019-04-18 |
| Compounds App 20190100517 - Bouillot; Anne Marie Jeanne ; et al. | 2019-04-04 |
| Antituberculosis Agent App 20190091224 - BALLELL PAGES; Lluis ; et al. | 2019-03-28 |
| D-proline Derivatives As Sap Depleting Agent App 20190060274 - DENIS; Alexis ; et al. | 2019-02-28 |
| Naphthyridine Derivatives As Alpha V Beta 6 Integrin Antagonists For The Treatment Of E.g. Fibrotic Diseases App 20190048005 - ANDERSON; Niall Andrew ; et al. | 2019-02-14 |
| Chemical Compounds App 20190040051 - ANDERSON; Niall Andrew ; et al. | 2019-02-07 |
| Ingenol Analogs, Pharmaceutical Compositions And Methods Of Use Thereof App 20190030029 - TAI; Vincent Wing-Fai ; et al. | 2019-01-31 |
| Novel Compounds As Rearranged During Transfection (ret) Inhibitors App 20190022078 - DEMARTINO; Michael P. ; et al. | 2019-01-24 |
| Compounds App 20190023715 - WAN; Zehong ; et al. | 2019-01-24 |
| Combination Treatments and Uses and Methods Thereof App 20190023791 - HOOS; Axel ; et al. | 2019-01-24 |
| Novel Compounds App 20190010135 - Chen; Weichun ; et al. | 2019-01-10 |
| Targeted Protein Degradation App 20190002578 - Brayshaw; Lewis Lee ; et al. | 2019-01-03 |
| NRF2 Regulators App 20190002454 - BOEHM; Jeffrey Charles ; et al. | 2019-01-03 |
| Substituted Benzazinones As Antibacterial Compounds App 20180362474 - JIN; Qi ; et al. | 2018-12-20 |
| Compounds App 20180354956 - Ding; Xiao ; et al. | 2018-12-13 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 